الاثنين، 16 يونيو 2014

ScienceDaily: Health & Medicine News

Health & Medicine News -- ScienceDaily

ScienceDaily: Health & Medicine News


Reversal of type 1 diabetes in mice may eventually help humans

Posted: 14 Jun 2014 04:26 PM PDT

Investigators have found a therapy that reverses new onset type 1 diabetes in mouse models and may advance efforts in combating the disease among humans. There is no cure for Type 1 diabetes though it can be controlled with insulin therapy. Symptoms of the disease include frequent urination, excessive thirst and weight loss even though you are eating more.

Canola oil may be an oil of choice for people with type 2 diabetes

Posted: 14 Jun 2014 12:03 PM PDT

New research suggests canola oil may be one of the oils of choice for people with Type 2 diabetes. Researchers compared people with Type 2 diabetes who ate either a low glycemic index diet that included bread made with canola oil, or a whole wheat diet known to reduce the risk of cardiovascular disease. The research found that those on the canola bread diet experienced both a reduction in blood glucose levels and a significant reduction in LDL, or "bad," cholesterol.

Improving diet quality reduces risk for type 2 diabetes

Posted: 14 Jun 2014 12:03 PM PDT

Improving the overall quality of one's diet helps to prevent type 2 diabetes, independent of other lifestyle changes, according to a new study. The study found that those who improved their diet quality index scores by 10 percent over four years -- by eating more whole grains, fruits and vegetables, and less sweetened beverages and saturated fats, for example -- reduced their risk for type 2 diabetes by about 20 percent, compared to those who made no changes to their diets.

Fasting reduces cholesterol levels in prediabetic people over extended period of time, new research finds

Posted: 14 Jun 2014 12:01 PM PDT

For prediabetics, many interventions focus on lifestyle changes and weight loss, but new research on periodic fasting has identified a biological process in the body that converts bad cholesterol in fat cells to energy, thus combating diabetes risk factors.

Testing Parkinson's disease immune-based drugs: New models

Posted: 12 Jun 2014 10:23 AM PDT

Using powerful, newly developed cell culture and mouse models of sporadic Parkinson's disease (PD), researchers have demonstrated that immunotherapy with specifically targeted antibodies may block the development and spread of PD pathology in the brain. By intercepting the distorted and misfolded alpha-synuclein (α-syn) proteins that enter and propagate in neurons, creating aggregates, the researchers prevented the development of pathology and also reversed some of the effects of already-existing disease.

Low cholesterol linked with worse survival in patients with kidney cancer

Posted: 12 Jun 2014 05:57 AM PDT

People are often told to reduce their cholesterol to improve their heart health, but new research suggests that low cholesterol may increase kidney cancer patients' risk of dying from their disease. The findings indicate that cholesterol testing may help doctors as they monitor and treat patients with kidney cancer.

Examining soccer players' productivity

Posted: 12 Jun 2014 05:51 AM PDT

The productivity of top goal
scorers in international football (soccer) is under study as FIFA World Cup gets underway. The researchers applied advanced econometric techniques to a sample of 66
 top goal scorers in the Union of European Football Associations (UEFA) 
Champions League between 1991 and 2011.

6,000 steps a day keeps knee OA limitations away

Posted: 12 Jun 2014 05:51 AM PDT

Walking reduces risk of functional limitation associated with knee osteoarthritis (OA), new research shows. In fact, the study suggests that walking 6,000 or more steps per day may protect those with or at risk of knee of OA from developing mobility issues, such as difficulty getting up from a chair and climbing stairs.

Weight loss critical to reduce burden of cardiovascular risk factors in obese patients with obstructive sleep apnea

Posted: 12 Jun 2014 05:50 AM PDT

Obesity and obstructive sleep apnea (OSA) tend to co-exist and are associated with a variety of cardiovascular risk factors, including inflammation, insulin resistance, abnormal cholesterol, and high blood pressure. While effective therapies are available for OSA, researchers are still unclear about what interventions are most effective in reducing the burden of risk factors for cardiovascular disease associated with OSA in obese patients.

Cancer drug boosts levels of vascular-protective gene, KLF2

Posted: 12 Jun 2014 05:50 AM PDT

An existing drug, bortezomib (Velcade), has been shown to help prevent clot development, new research shows. In 2008, the Food and Drug Administration approved bortezomib (Velcade) to treat multiple myeloma, which is a type of bone cancer and mantle cell lymphoma -- a particularly aggressive form of non-Hodgkin lymphoma. In addition to attacking cancer cells, the drug has been shown to help prevent clot development common to many forms of the disease.

ليست هناك تعليقات:

إرسال تعليق